- Home
- UHT vs BIOA Comparison
UHT vs BIOA Comparison
Compare UHT & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UHT | BIOA |
|---|---|---|
| Founded | 1986 | 2015 |
| Country | United States | United States |
| Employees | N/A | 62 |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 586.9M | 681.9M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | UHT | BIOA |
|---|---|---|
| Price | $40.49 | $16.56 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $43.00 | ★ $51.50 |
| AVG Volume (30 Days) | 51.0K | ★ 383.2K |
| Earning Date | 04-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 7.33% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | ★ $99,190,000.00 | N/A |
| Revenue This Year | $2.12 | $720.93 |
| Revenue Next Year | $2.94 | N/A |
| P/E Ratio | $112.81 | ★ N/A |
| Revenue Growth | ★ 0.18 | N/A |
| 52 Week Low | $35.26 | $3.93 |
| 52 Week High | $44.70 | $24.00 |
Technical Indicators
Market Signals| Indicator | UHT | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 41.77 | 45.48 |
| Support Level | $39.51 | $15.49 |
| Resistance Level | $41.15 | $19.01 |
| Average True Range (ATR) | 0.78 | 1.19 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 25.17 | 39.50 |
Price Performance
Historical ComparisonAbout UHT Universal Health Realty Income Trust
Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.
About BIOA BioAge Labs Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.